Abstract
We studied the healing efficacy of cimetidine or placebo in 23 endoscopically proven duodenal ulcer outpatients in a randomized, controlled, prospective, double-blind trial. There were 11 patients in the cimetidine (1200 mg daily) treatment group and 12 patients in the placebo-treated group. No antacid was allowed, but a placebo antacid with no neutralizing capacity was given as needed for pain. The incidence of complete endoscopic healing at 2, 4, and 6 weeks was 54%, 63%, and 72% in the cimetidine-treated patients and 8%, 50%, and 67% in the placebo-treated patients. There was a statistically significant difference (P<0.05) in complete duodenal ulcer healing between both treatment groups after 2 weeks of therapy, but there was no significant difference at the 4- and 6-week observation periods. The incidence of complete pain relief at 2 and 4 weeks was 64% and 82% in the cimetidine-treated patients and 67% and 75% in the placebo-treated patients. At 6 weeks of treatment there was no increase in the number of patients with complete pain relief in either group. There was no significant difference between the two groups in the incidence of ulcer pain relief at any of the three observation periods. Duodenal ulcer healing rates and duodenal ulcer pain relief were compared at 2, 4, and 6 weeks. There was no statistical association between ulcer healing and complete pain relief in the placebo treatment group at the 2-week evaluation period, but there was statistical association (P<0.05) in the cimetidine treatment group at 2 weeks and both treatment groups at the 4- and 6-week evaluation periods. The results of this study demonstrate that in duodenal ulcer outpatients treated for 6 weeks: (1) cimetidine increases the incidence of duodenal ulcer healing during the first 2 weeks of treatment; (2) more than 50% of duodenal ulcers will spontaneously heal during a 4 to 6-week observation period which is not statistically modified by cimetidine treatment; (3) the complete relief of duodenal ulcer pain is not influenced by treatment with cimetidine when compared to placebo.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gray GR, Smith IS, Mackenzie I, et al: Oral cimetidine in severe duodenal ulceration: A double-blind controlled trial. Lancet 1:4, 1977
Bardhan KD, Saul DM, Edwards JL, et al: Comparison of two doses of cimetidine and placebo in the treatment of duodenal ulcer: a multicenter trial. Gut 20:68–74, 1979
Blackwood WS, Pickard RG, Maudgal DP, et al: Cimetidine in duodenal ulcer: Controlled trial. Lancet 2:174–176, 1976
Bodemar G, Walan A: Cimetidine in the treatment of active duodenal and prepyloric ulcers. Lancet 2:161–164, 1976
Hetzel DJ, hansky J, Shearman DJC, et al: Cimetidine treatment of duodenal ulceration: Short term clinical trial and maintenance study. Gastroenterology 74:389–392, 1978
Binder HJ, Cocco A, Crossley RJ, et al: Cimetidine in the treatment of duodenal ulcer: A multicenter double blind study. Gastroenterology 74:380–388, 1978
Cochran WG, Cox GM: Experimental Designs. Chapter 4, Statistical analysis with data arranged in two classes. New York, John Wiley & Sons, 1957, pp. 103–105
Dixon WJ, Massey Jr, FJ: Introduction to Statistical Analysis. Chapter 8, Test of hypotheses concerning the means of two populations. New York, McGraw-Hill, 1969, pp. 114–119
Hollander D, Harlan J: Antacids vs placebo in peptic ulcer therapy: A controlled double-blind investigation. J Am Med Assoc 226:1181–1185, 1973
Kum Lam S, Chun Lam K, Lung Lai C, et al: Treatment of duodenal ulcer with antacid and sulpiride: A double-blind controlled study. Gastroenterology 76:315–322, 1979
Peterson WL, Sturdevant RAL, Franki HD et al: Healing of duodenal ulcer with an antacid regimen. N Engl J Med 297:341–345, 1977
Scheurer U, Witzel L, Halter F, et al: Gastric and duodenal ulcer healing under placebo treatment. Gastroenterology 72:838–841, 1977
Sun DCH, Stempien SJ: Site and size of the ulcer as determinants of outcome. Gastroenterology 61:576–584, 1971
Gudjonsson B, Spiro HM: Response to placebo in ulcer disease. Am J Med 65:399–402, 1978
Doll R, Pugott F: Factors influencing the rate of healing of gastric ulcers. Lancet 1:171–175, 1952
Butler ML, Gersh H: Antacid vs placebo in hospitalized gastric ulcer patients: A controlled therapeutic study. Am J Dig Dis 20:803–807, 1975
Sturdevant RAL, Isenberg J, Secrest D: Antacid and placebo produces similar pain relief in duodenal ulcer patients. Gastroenterology 72:1–5, 1977
Gray GR, Smith IS, MacKenzie I, et al: Long term cimetidine in the management of severe duodenal ulcer dyspepsia. Gastroenterology 74:397–401, 1978
Blackwood WS, Maudgas DP, Northfield TC: Prevention by bedtime cimetidine of duodenal-ulcer relapse. Lancet 1:626–627, 1978
Bodemar G, Walan A: Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet 1:403–407, 1978
Bardhan KD, Saul DM, Edwards JL, et al: Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration. Gut 20:158–162, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Collen, M.J., Hanan, M.R., Maher, J.A. et al. Cimetidine vs placebo in duodenal ulcer therapy. Digest Dis Sci 25, 744–749 (1980). https://doi.org/10.1007/BF01345292
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01345292